Roche wins UK watchdog's nod for lymphoma drug after initial snub

ZURICH (Reuters) – Britain’s healthcare watchdog (NICE) recommended Roche’s medicine Gazyvaro for previously untreated advanced follicular lymphoma patients after initially rejecting the Swiss drugmaker’s medicine last year as too expensive.


Source: Reuters Health

Leave a Reply

Your email address will not be published. Required fields are marked *